Scott Max Herbig

USPTO Granted Patents = 22 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 13

Forward Citations = 608(Granted Patents)

Location History:

Groton, CT (US) (1994 - 1997)
Becd, OR (US) (1997)
Bend, OR (US) (1992 - 1999)
East Lyme, CT (US) (2003 - 2022)

Company Filing History:

Years Active: 1992-2022

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11253523 - Tofacitinib oral sustained release dosage forms (2022-02-22),

2. 10639309 - Tofacitinib oral sustained release dosage forms (2020-05-05),

3. 9937181 - Tofacitinib oral sustained release dosage forms (2018-04-10),

4. 8431159 - Solid pharmaceutical dispersions with enhanced bioavailability (2013-04-30),

5. 8367118 - Solid pharmaceutical dispersions with enhanced bioavailability (2013-02-05),

6. 8337899 - Solid pharmaceutical dispersions with enhanced bioavailability (2012-12-25),

7. 8263128 - Solid pharmaceutical dispersions with enhanced bioavailability (2012-09-11),

8. 8257741 - Solid pharmaceutical dispersions with enhanced bioavailability (2012-09-04),

9. 7887844 - Multiparticulate crystalline drug compositions having controlled release profiles (2011-02-15),

10. 7550158 - Controlled release by extrusion of solid amorphous dispersions of drugs (2009-06-23),

11. 6984403 - Azithromycin dosage forms with reduced side effects (2006-01-10),

12. 6706283 - Controlled release by extrusion of solid amorphous dispersions of drugs (2004-03-16),

13. 6641840 - Sustained release formulations for growth hormone secretagogues (2003-11-04),

14. 6517866 - Sertraline salts and sustained-release dosage forms of sertraline (2003-02-11),

15. 5876752 - Use of interfacially-polymerized membranes in delivery devices (1999-03-02),

Title: Scott Max Herbig: A Visionary Inventor Shaping the Future of Innovation

Introduction:

Scott Max Herbig, a visionary inventor based in East Lyme, CT (US), has made significant contributions to the world of technology. His passion for innovation and relentless pursuit of excellence have solidified his reputation as a pioneer in the field.

Latest Patents:

With an impressive portfolio of 22 patents, Scott Max Herbig is known for his groundbreaking work in developing oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts. These formulations exhibit desirable pharmacokinetic characteristics, showcasing his expertise in the pharmaceutical industry.

Career Highlights:

Having worked at Pfizer Corporation and Bend Research, Inc., Scott Max Herbig has gained invaluable experience and insights into the realm of technology and pharmaceuticals. His innovative approaches and dedication to excellence have led to the development of cutting-edge solutions that have the potential to revolutionize the industry.

Collaborations:

Throughout his career, Scott Max Herbig has collaborated with esteemed professionals in the field, including William John Curatolo and James A S Nightingale. These collaborations have further enriched his work, allowing for cross-pollination of ideas and expertise to drive innovation forward.

Conclusion:

Scott Max Herbig's visionary approach to invention and unwavering commitment to excellence continue to inspire and shape the future of innovation. His remarkable contributions to the technology and pharmaceutical sectors underscore his status as a leading inventor, poised to make a lasting impact on the world.

This text is generated by artificial intelligence and may not be accurate.